What is the ticker symbol for Climb Bio?

Climb Bio trades under the ticker CLYM on NASDAQ.

What sector does Climb Bio operate in?

Climb Bio is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CLYM in a portfolio?

PortView shows CLYM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Climb Bio (CLYM) Stock Analysis

NASDAQHealthcareBiotechnology

$14.60-1.48%

1-year price historyRange $1.64 – $17.84

52-week range$14.60

$1.54$18.33

What Climb Bio does

Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.

Key metrics

Market cap

$836.04M

P/E (TTM)

-17.59

EPS (TTM)

$-0.83

Beta

0.07

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$13.89

200-day avg

$8.51

52-week high

$18.33

52-week low

$1.54

CEO

Aoife Brennan BCh MMSc

ETFs linked to CLYM

Broad-market and Healthcare sector ETFs an investor holding Climb Bio is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CLYM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CLYM in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Climb Bio?: Climb Bio trades under the ticker CLYM on NASDAQ.
Which exchange is CLYM listed on?: CLYM is listed on NASDAQ.
What sector does Climb Bio operate in?: Climb Bio is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CLYM in a portfolio?: PortView shows CLYM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.